Catharina Ziekenhuis Stichting — Sponsor Intelligence | 7 EU Trials

Filter these 7 trials by condition, phase, country and more.

Open in Search →

7 Registered trials

4 Recruiting

1 Completed trials

5 Countries active

10 Unique IMPs

100% Results reported

Phase III

Phase II/III

Phase II

Phase III: 3 Phase II/III: 1 Phase II: 3

100%

1 of 1 completed trials have published summary results (EU CTR Article 37 — 12-month obligation).

View full Transparency Scoreboard →

Top indications

Rectal cancer 2 Rectal cancer recurrent 1

Top IMPs

IRINOTECAN HYDROCHLORIDE TRIHYDRATE 6 FLUOROURACIL 5 OXALIPLATIN 5 FOLINIC ACID 4 CAPECITABINE 2 BEVACIZUMAB 1 BUPIVACAINE HYDROCHLORIDE, ANHYDROUS 1 CALCIUM FOLINATE 1 SODIUM CHLORIDE 1 TEGAFUR, GIMERACIL, OTERACIL 1

All trials

7 total

Intraperitoneal irinotecan with concomitant FOLFOX and bevacizumab for patients with unresectable colorectal peritoneal metastases – a phase… Pending

2024-517152-34-00 Phase II 1 country IRINOTECAN HYDROCHLORIDE TRIHYDRATE
Chemo-immunotherapy before and after surgery for peritoneal metastases of large bowel cancer. Pending

2024-518570-13-00 Phase II/III 2 countries BEVACIZUMAB; CAPECITABINE; FLUOROURACIL; FOLINIC ACID; IRINOTECAN HYDROCHLORIDE …
Neoadjuvant FOLFOXIRI and Chemoradiotherapy versus Neoadjuvant CAPOX/FOLFOX and Chemoradiotherapy, followed by Surgery or a Watch-and-Wait A… Recruiting

2025-523692-39-00 Phase III 1 country FLUOROURACIL; FOLINIC ACID; IRINOTECAN HYDROCHLORIDE TRIHYDRATE; OXALIPLATIN
Continuous Wound Infiltration versus placebo following elective minimally invasive colorectal surgery; a double-blinded, randomised, placebo… Recruiting

2024-512107-39-00 Phase III 1 country BUPIVACAINE HYDROCHLORIDE, ANHYDROUS; SODIUM CHLORIDE
Personalized dosing of FOLFIRINOX in pancreatic cancer patients: a phase-2 pharmacokinetic, safety and feasibility trial Recruiting

2024-510576-21-00 Phase II 1 country CALCIUM FOLINATE; FLUOROURACIL; IRINOTECAN HYDROCHLORIDE TRIHYDRATE; OXALIPLATIN
Multicentre, open-label, randomized, controlled, parallel arms clinical trial of induction chemotherapy followed by chemoradiotherapy versus… Recruiting

2024-512526-28-00 Phase III 5 countries CAPECITABINE; FLUOROURACIL; FOLINIC ACID; IRINOTECAN HYDROCHLORIDE TRIHYDRATE; O…
Induction chemotherapy for locally advanced rectal cancer. Ended

2023-509758-74-00 Phase II 1 country FLUOROURACIL; FOLINIC ACID; IRINOTECAN HYDROCHLORIDE TRIHYDRATE; OXALIPLATIN

Showing 1–7 of 7 trials

← All sponsors A–Z